This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
No specific study design were stipulated by the authors as inclusion criteria.
Sources searched to identify primary studies
Not stated.
Criteria used to ensure the validity of primary studies
Methods used to judge relevance and validity, and for extracting data
Number of primary studies included
The authors reviewed 4 studies in total. A sub-total of 2 were used as the sources of effectiveness.
Methods of combining primary studies
Narrative method.
Investigation of differences between primary studies
Results of the review
The ratios of detection rate at prevalence screening and incidence rate in the situation without screening (study conducted in 1988) were 1.8 (incidence in control group: 1.9), 3.5 (incidence in control group: 3.0), 4.7 (incidence control group: 3.8) and 4.4 (incidence control group: 5.4) in the age classes 40-49, 50-59, 60-69 and 70-74, respectively. The corresponding figures derived from a study conducted in 1977 were 3.0 (ages 40-44), 3.8 (ages 45-49), 3.3 (ages 50-54), 4.0 (ages 55-59), 3.6 (ages 60-64) and 4.7 (ages 65-74). The corresponding figures derived from a trial with unpublished data were 1.0 (ages 40-44), 2.5 (ages 45-49), 2.8 (ages 50-54), 2.4 (ages 55-59), 2.5 (ages 60-64), 7.2 (ages 65-69), 3.0 (ages 70-74), 4.0 (ages 75-79) and 3.4 (ages 80-84). The values adopted for the optimistic variant were 2.0 (ages 50-54), 2.3 (ages 55-59), 2.8 (ages 60-64), 3.4 (ages 65-69), 3.6 (ages 70-74), 3.9 (ages 75-79), and 4.0 (ages 80-84). The corresponding values for the pessimistic variant were 2.0, 2. 3, 2.8, 3.4, 4.6, 6.0, and 8.4 respectively.
Methods used to derive estimates of effectiveness
Effectiveness estimates were also derived from the authors' assumptions.
Estimates of effectiveness and key assumptions
For demonstration purposes, an attendance rate was assumed to be 100%. For calculating cost-effectiveness ratios, attendance rates were from 75% at age 51 years, to 61% at age 71 years and 21% at age 81 years.
